Galapagos Withdraws Jyseleca Applications in Europe and Revises Sales Projections

Galapagos Withdraws Jyseleca Applications in Europe and Revises Sales Projections

Galapagos, a Belgium biotech company, has experienced setbacks with its drug Jyseleca (filgotinib). Based on the results of a phase…

Read More »